People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

The renowned musician says he plans to keep playing, after confirming the long-suspected diagnosis.

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Ozzy Osbourne is struggling to walk amid his battle with Parkinson’s disease — but his singing voice is “as good as ever,” ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U.K.. Osbourne, 76, has been ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...